+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of anti hbs immunity in patients vaccinated with human plasma derived or with recombinant derived vaccine



Evaluation of anti hbs immunity in patients vaccinated with human plasma derived or with recombinant derived vaccine



European Journal of Clinical Investigation 21(2 Part 2): 13




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031315799

Download citation: RISBibTeXText


Related references

Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine. Research In Virology. 148(2): 109-114, 1997

Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine. Vaccine. 13(2): 139-141, 1995

Booster response to recombinant yeast-derived hepatitis B vaccine in vaccinees whose anti-HBs responses were initially elicited by a plasma-derived vaccine. Vaccine 9(10): 765-767, 1991

Comparative evaluation of the immunogenicity of yeast-derived (recombinant) and plasma-derived hepatitis B vaccine in infants. Journal of Medical Virology 35(4): 297-302, 1991

Clinical evaluation of low dose intradermally administered hepatitis B vaccine: a comparison of plasma-derived and recombinant yeast-derived vaccines. Vaccine 10(5): 301-304, 1992

Anti pre s2 and anti hbs responses in hemophiliacs vaccinated with a plasma derived vaccine a four year follow up study. Coursaget, P And M J Tong (Ed ) Colloque Inserm (Institut National De La Sante Et De La Recherche Medicale), Vol 194 Progress in Hepatitis B Immunization; (Inserm (National Institute Of Health And Medical Research) Colloquium), Vol 194 Progress in Hepatitis B Immunization Xlxi+547p Inserm/John Libbey Eurotext: Montrouge, France; London, England, Uk Illus Paper 79-86, 1990

A randomized double-blind clinical trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine compared with a plasma-derived vaccine. Archives of Internal Medicine 150(6): 1195-1200, 1990

Immunity to hepatitis B in two birth cohorts given plasma-derived or yeast-derived vaccine. New Zealand Medical Journal 112(1095): 331-333, 1999

Hepatitis b vaccination in mentally retarded patients recombinant vaccine versus plasma derived vaccine. Zuckerman, A J (Ed ) Viral Hepatitis And Liver Disease; International Symposium, London, England, Uk, May 26-28, 1987 Xxi+1136p Alan R Liss, Inc : New York, New York, Usa Illus Maps 1068-1070, 1988

Comparison of a recombinant s plus pres2 candidate vaccine and a plasma derived hbv vaccine in high risk patients. Hepatology 14(4 Part 2): 217A, 1991

Comparative immunogenicity in children of mammalian cell-derived recombinant hepatitis B vaccine and plasma-derived hepatitis B vaccine. Vaccine 10(6): 379-382, 1992

Waning immunity and booster responses in nursing and medical technology students who had received plasma-derived or recombinant hepatitis B vaccine during infancy. American Journal of Infection Control 39(5): 408-414, 2011

Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine. Vaccine 30(20): 3090-3096, 2012